|
| Press Releases |
|
 |
|
| Friday, November 7, 2014 |
|
|
INC Research Announces Pricing of Initial Public Offering |
| INC Research Holdings, Inc. (INC Research), a leading, global Phase I to IV contract research organization, today announced the pricing of its initial public offering of 8,108,108 shares of its Class A common stock at a price to the public of $18.50 per share. more info >> |
|
| Tuesday, October 7, 2014 |
|
|
INC Research Files Registration Statement for Initial Public Offering |
| INC Research Holdings, Inc. (INC Research), a leading, global Phase I to IV contract research organization, today announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) related to a proposed initial public offering of its common stock. more info >> |
|
| Friday, October 3, 2014 |
|
|
INC Research Demonstrates Continued Dedication to Site Relationships at 2014 SCRS Site Solutions Summit |
| INC Research, a leading, global Phase I to IV clinical research organization (CRO), today announced plans for an extensive presence at the 2014 Society for Clinical Research Sites' (SCRS) Site Solutions Summit taking place Oct. 10-12, 2014, on Amelia Island, Fla. more info >> |
|
| Thursday, October 2, 2014 |
|
|
INC Research Further Reinforces Commitment to Clinical Research Sites and Patients through Creation of New Leadership Role |
| INC Research, a leading, global Phase I to IV contract research organization (CRO), today announced Clare Grace, PhD, has joined the Company as Vice President, Site and Patient Access. more info >> |
|
| Wednesday, August 6, 2014 |
|
|
INC Research's Tara Fitzgerald and Judy Swilley Named to Annual PharmaVOICE 100 |
| INC Research, a leading, global Phase I to IV contract research organization (CRO), today announced that Tara Fitzgerald, Executive Vice President, Biometrics and Judy Swilley, PhD, Executive Vice President, Global Clinical Operations and Alliance Management, have been named to the annual PharmaVOICE 100 list of the most inspiring people in the life sciences industry. more info >> |
|
| Wednesday, July 30, 2014 |
|
|
INC Research Appoints Jan Schreur Senior Vice President, Human Resources |
| INC Research, a leading, global Phase I to IV contract research organization (CRO), today announced it has appointed Jan Schreur as the Company's Senior Vice President, Human Resources. more info >> |
|
| Thursday, July 17, 2014 |
|
|
INC Research Drives Deeper Site Connections Through Strengthened Study Start-up Effort |
| INC Research, a leading, global Phase I to IV clinical research organization (CRO), today announced the promotion of Carol Aliyar to Senior Vice President, Study Start-Up. more info >> |
|
| Wednesday, July 16, 2014 |
|
|
INC Research, LLC Second Quarter 2014 Results of Operations Release Date and Conference Call |
| INC Research, LLC (the "Company"), a leading, global Phase I to Phase IV clinical research organization (CRO), will conduct a conference call to discuss its second quarter 2014 financial results at 10:00 a.m. ET on Wednesday, August 13, 2014. more info >> |
|
| Thursday, June 12, 2014 |
|
|
INC Research Strengthens Connections with Drug Development Community at DIA 2014 Annual Meeting |
| INC Research, a leading, global Phase I to IV clinical research organization (CRO), will be showcasing its latest advancements in clinical trial innovation at the DIA 2014 Annual Meeting being held June 15-19 at the San Diego Convention Center. more info >> |
|
| Thursday, May 29, 2014 |
|
|
INC Research Debuts New Interactive Website |
| INC Research, a leading global Phase I to IV clinical research organization (CRO), today announced the launch of an all-new website (www.incresearch.com) to deliver an interactive digital experience for stakeholders across the clinical development process. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
国资护航+技术壁垒+优质保荐 华芢生物（02396.HK）PDGF管线直指18A赛道确定性价值
Dec 15, 2025 11:05 HKT/SGT
|
|
|
TransNusa Secures 19 Scheduled Flight Routes Within Three Years of Operations
Dec 15, 2025 09:51 HKT/SGT
|
|
|
國資護航+技術壁壘+優質保薦 華芢生物（02396.HK）PDGF管線直指18A賽道確定性價值
Dec 15, 2025 09:28 HKT/SGT
|
|
|
Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership
Dec 15, 2025 8:30 JST
|
|
|
韓国の主要人物・金載德氏がMOVA Chain支援を表明、エコシステム発展が新段階へ
Dec 13, 2025 13:00: JST
|
|
|
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST
|
|
|
京東工業登陸港交所：業績與品牌雙賦能 長期成長潛力可期
Dec 12, 2025 17:05 HKT/SGT
|
|
|
京东工业登陆港交所：业绩与品牌双赋能 长期成长潜力可期
Dec 12, 2025 17:04 HKT/SGT
|
|
|
京東工業配售結果出爐：MRO龍頭實力領跑 全鏈條數智化解決方案釋放長期價值
Dec 12, 2025 17:00 HKT/SGT
|
|
|
京东工业配售结果出炉：MRO龙头实力领跑 全链条数智化解决方案释放长期价值
Dec 12, 2025 17:00 HKT/SGT
|
|
|
全鏈條服務+業績高增長彰顯實力 京東工業港交所上市釋放長期價值
Dec 12, 2025 15:54 HKT/SGT
|
|
|
全链条服务+业绩高增长彰显实力 京东工业港交所上市释放长期价值
Dec 12, 2025 15:54 HKT/SGT
|
|
|
首隻山水實景表演概念股 印象大紅袍啟動香港公開募股
Dec 12, 2025 15:01 HKT/SGT
|
|
|
首只山水实景表演概念股 印象大红袍启动香港公开募股
Dec 12, 2025 15:00 HKT/SGT
|
|
|
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Dec 12, 2025 14:35 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
